Home » Topics » BioWorld Science

BioWorld Science
RSS

p38Gamma as a novel therapeutic target in human colorectal cancer

Sep. 19, 2019

EGPI-1 as a promising new anticancer agent that targets the eIF4E/eIF4G interface

Sep. 19, 2019

Mitochondria differ between cell types

Sep. 19, 2019

Methylation patterns, AI identify metastases

Sep. 19, 2019

Imotope shows promise in EAE model

Sep. 19, 2019

Aspartylglycosamine as a potential new biochemical marker of NGLY1-CDDG

Sep. 19, 2019

Ra's zilucoplan selected for evaluation in ALS platform trial

Sep. 18, 2019

Durect completes phase IIa trial of DUR-928 in alcoholic hepatitis

Sep. 18, 2019

Antisense Therapeutics reports preliminary phase II data on ATL-1102 in Duchenne muscular dystrophy

Sep. 18, 2019

FDA clears IND for Ceraxa in AML

Sep. 18, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...